FDA Committee Delays Review of Pfizer-BioNTech’s COVID-19 Vaccine for Young Kids
1 min read
FDA Committee Delays Review of Pfizer-BioNTech’s COVID-19 Vaccine for Young Kids
The U.S. Food and also Drug Administration (FDA) delayed a conference to review the consent of Pfizer-BioNTech’s COVID-19 vaccination for kids younger than five, once again pushing back the timeline for immunizing the youngest Americans. The FDA’s Vaccines and R.